Pan-HER Tyrosine Kinase Inhibitor Pyrotinib Enhances Radiosensitivity via ERK1/2 Pathway in HER2-Positive Gastric Cancer
Qian Niu(Tongji Hospital), Xianglin Yuan(Tongji Hospital)
Cited by 6
Related Papers
Nintedanib enhances the efficacy of PD-L1 blockade by upregulating MHC-I and PD-L1 expression in tumor cells
|Theranostics|2021|72
The Thr300Ala variant of ATG16L1 is associated with decreased risk of brain metastasis in patients with non-small cell lung cancer
|Autophagy|2017|40
Pyrotinib enhances the radiosensitivity of HER2‑overexpressing gastric and breast cancer cells
|Oncology Reports|2020|30
Kinsenoside Protects Against Radiation-Induced Liver Fibrosis via Downregulating Connective Tissue Growth Factor Through TGF-β1 Signaling
|Frontiers in Pharmacology|2022|15
Aerosolized Thyroid Hormone Prevents Radiation Induced Lung Fibrosis
|Frontiers in Oncology|2020|14